دورية أكاديمية

Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis

التفاصيل البيبلوغرافية
العنوان: Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
المؤلفون: Saver, Jeffrey L., Goyal, Mayank, van der Lugt, Aad, Menon, Bijoy K., Majoie, Charles B. L. M., Dippel, Diederik W., Campbell, Bruce C., Nogueira, Raul G., Demchuk, Andrew M., Tomasello, Alejandro, Cardona, Pere, Devlin, Thomas G., Frei, Donald F., de Rochemont, Richard du Mesnil, Berkhemer, Olvert A., Jovin, Tudor G., Siddiqui, Adnan H., van Zwam, Wim H., Davis, Stephen M., Castao, Carlos, Sapkota, Biggya L., Fransen, Puck S., Molina, Carlos, van Oostenbrugge, Robert J., Chamorro, Angel, Lingsma, Hester, Silver, Frank L., Donnan, Geoffrey A., Shuaib, Ashfaq, Brown, Scott, Stouch, Bruce, Mitchell, Peter J., Davalos, Antoni, Roos, B. W. E. M., Hill, Michael D.
المصدر: Saver , J L , Goyal , M , van der Lugt , A , Menon , B K , Majoie , C B L M , Dippel , D W , Campbell , B C , Nogueira , R G , Demchuk , A M , Tomasello , A , Cardona , P , Devlin , T G , Frei , D F , de Rochemont , R D M , Berkhemer , O A , Jovin , T G , Siddiqui , A H , van Zwam , W H , Davis , S M , Castao ....
سنة النشر: 2016
المجموعة: Maastricht University Research Publications
الوصف: IMPORTANCE Endovascular thrombectomy with second-generation devices is beneficial for patients with ischemic stroke due to intracranial large-vessel occlusions. Delineation of the association of treatment time with outcomes would help to guide implementation. OBJECTIVE To characterize the period in which endovascular thrombectomy is associated with benefit, and the extent to which treatment delay is related to functional outcomes, mortality, and symptomatic intracranial hemorrhage. DESIGN, SETTING, AND PATIENTS Demographic, clinical, and brain imaging data as well as functional and radiologic outcomes were pooled from randomized phase 3 trials involving stent retrievers or other second-generation devices in a peer-reviewed publication (by July 1, 2016). The identified 5 trials enrolled patients at 89 international sites. EXPOSURES Endovascular thrombectomy plus medical therapy vs medical therapy alone; time to treatment. MAIN OUTCOMES AND MEASURES The primary outcome was degree of disability (mRS range, 0-6; lower scores indicating less disability) at 3 months, analyzed with the common odds ratio (cOR) to detect ordinal shift in the distribution of disability over the range of the mRS; secondary outcomes included functional independence at 3 months, mortality by 3 months, and symptomatic hemorrhagic transformation. RESULTS Among all 1287 patients (endovascular thrombectomy + medical therapy [n = 634]; medical therapy alone [n = 653]) enrolled in the 5 trials (mean age, 66.5 years [SD, 13.1]; women, 47.0%), time from symptom onset to randomization was 196 minutes (IQR, 142 to 267). Among the endovascular group, symptom onset to arterial puncture was 238 minutes (IQR, 180 to 302) and symptom onset to reperfusion was 286 minutes (IQR, 215 to 363). At 90 days, the mean mRS score was 2.9 (95% CI, 2.7 to 3.1) in the endovascular group and 3.6 (95% CI, 3.5 to 3.8) in the medical therapy group. The odds of better disability outcomes at 90 days (mRS scale distribution) with the endovascular group declined with longer ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1001/jama.2016.13647
الإتاحة: https://doi.org/10.1001/jama.2016.13647Test
https://cris.maastrichtuniversity.nl/en/publications/128e650c-f44c-444a-8288-b912d4d78c6eTest
حقوق: info:eu-repo/semantics/closedAccess
رقم الانضمام: edsbas.493EBFE8
قاعدة البيانات: BASE